185 related articles for article (PubMed ID: 34109123)
1. Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers.
Berg J; Ramberg C; Haugstvedt JOS; Bengtson MB; Gabrielsen AM; Brustugun OT; Halvorsen AR; Helland Å
Front Oncol; 2021; 11():674731. PubMed ID: 34109123
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
4. Radiation pneumonitis after stereotactic radiation therapy for lung cancer.
Yamashita H; Takahashi W; Haga A; Nakagawa K
World J Radiol; 2014 Sep; 6(9):708-15. PubMed ID: 25276313
[TBL] [Abstract][Full Text] [Related]
5. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
6. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
7. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?
Guckenberger M; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Grills IS
J Thorac Oncol; 2012 Mar; 7(3):542-51. PubMed ID: 22258475
[TBL] [Abstract][Full Text] [Related]
8. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
[TBL] [Abstract][Full Text] [Related]
9. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
10. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
[TBL] [Abstract][Full Text] [Related]
12. [Stereotactic lung radiotherapy: Technical setting up on Novalis Tx
Bellière-Calandry A; Dupic G; Magnier F; Chassin V; Dedieu V; Lapeyre M
Cancer Radiother; 2017 Jun; 21(4):291-300. PubMed ID: 28522279
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy feasibility for patients with peripheral stage I lung cancer and poor pulmonary function.
Koba A; Hayashi K; Suzuki O; Kawaguchi Y; Ogawa K; Chatani M
Oncol Lett; 2020 Mar; 19(3):2515-2521. PubMed ID: 32194753
[TBL] [Abstract][Full Text] [Related]
14. Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study.
Dong B; Chen R; Zhu X; Wu Q; Jin J; Wang W; Zhu Y; Jiang H; Bi N; Wang X; Xu X; Xu Y; Chen M
Clin Transl Radiat Oncol; 2023 May; 40():100601. PubMed ID: 36936471
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).
Lischalk JW; Woo SM; Kataria S; Aghdam N; Paydar I; Repka MC; Anderson ED; Collins BT
J Radiat Oncol; 2016; 5(4):379-387. PubMed ID: 28018523
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.
Navarro-Martin A; Aso S; Cacicedo J; Arnaiz M; Navarro V; Rosales S; de Blas R; Ramos R; Guedea F
J Thorac Oncol; 2016 Jul; 11(7):1101-11. PubMed ID: 27103512
[TBL] [Abstract][Full Text] [Related]
18. Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Kita N; Tomita N; Takaoka T; Okazaki D; Niwa M; Torii A; Takano S; Mekata Y; Niimi A; Hiwatashi A
Clin Transl Radiat Oncol; 2023 Jul; 41():100648. PubMed ID: 37346273
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Machuzak M; Mazzone P; Videtic GM
J Thorac Oncol; 2009 Jul; 4(7):838-44. PubMed ID: 19487961
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with cavity formation after stereotactic body radiation therapy for peripheral early-stage lung cancer.
Maebayashi T; Ishibashi N; Sakaguchi M; Aizawa T; Sato A; Saito T; Kawamori J; Tanaka Y
Radiol Med; 2024 Mar; 129(3):507-514. PubMed ID: 38286868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
